HR18034 clinical trials
Also written HR18034.
How each study uses HR18034 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HR18034
- 5
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Who runs them
Industry 6 · Other 0
Shanghai Hengrui Pharmaceutical Co., Ltd. (5) · Jiangsu HengRui Medicine Co., Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses HR18034 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKATerminatedPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT06509958Written as HR18034
- A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing HemorrhoidectomyCompletedPhase 3Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05769855Written as HR18034
- Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain ManagementActive, not recruitingPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05561309Written as HR18034;Ropivacaine Hydrochloride Injection
- A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy.CompletedPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05376904Written as HR18034
- Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain ManagementStatus unknownPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05744674Written as HR18034
- A Trial of HR18034 in Inguinal Hernia RepairStatus unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT04551924Written as HR18034